Author:
Ros J.,Matito J.,Villacampa G.,Comas R.,Garcia A.,Martini G.,Baraibar I.,Saoudi N.,Salvà F.,Martin Á.,Antista M.,Toledo R.,Martinelli E.,Pietrantonio F.,Boccaccino A.,Cremolini C.,Dientsmann R.,Tabernero J.,Vivancos A.,Elez E.
Reference30 articles.
1. Mutations of the BRAF gene in human cancer;Davies;Nature,2002
2. BRAF V600E mutant colorectal cancer subtypes based on gene expression;Barras;Clin Cancer Res,2017
3. The evolving treatment landscape in BRAF-V600E-mutated metastatic colorectal cancer;Tabernero;Am Soc Clin Oncol Educ Book,2022
4. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies;Clarke;J Gastrointest Oncol,2015
5. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis;De Roock;Lancet Oncol,2010
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献